Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 61 results.
User Information
Export Records
  1. 1.   Three small partner proteins facilitate the type VII-dependent secretion of an antibacterial nuclease
  2. Yang, Yaping; Boardman, Eleanor; Deme,Justin; Alcock, Felicity; Lea,Susan; Palmer, Tracy
  3. mBio. 2023, Oct 10; e0210023.
  1. 2.   Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody
  2. Asokan, Mangaiarkarasi; Dias, Joana; Liu, Cuiping; Maximova, Anna; Ernste, Keenan; Pegu, Amarendra; McKee, Krisha; Shi, Wei; Chen, Xuejun; Almasri, Cassandra; Promsote, Wanwisa; Ambrozak, David R; Gama, Lucio; Hu, Jianfei; Douek, Daniel C; Todd, John-Paul; Lifson,Jeffrey; Fourati, Slim; Sekaly, Rafick P; Crowley, Andrew R; Ackerman, Margaret E; Ko, Sung Hee; Kilam, Divya; Boritz, Eli A; Liao, Laura E; Best, Katharine; Perelson, Alan S; Mascola, John R; Koup, Richard A
  3. Proceedings of the National Academy of Sciences of the United States of America. 2020, AUG 4; 117(31): 18754-18763.
  1. 3.   Akt Regulates a Rab11-Effector Switch Required for Ciliogenesis
  2. Walia, Vijay; Cuenca,Adrian; Vetter, Melanie; Insinna, Christine; Perera, Sumeth; Lu,Quanlong; Ritt,Daniel; Semler, Elizabeth; Specht,Suzanne; Stauffer,Jimmy; Morrison,Deborah; Lorentzen, Esben; Westlake,Christopher
  3. Developmental cell. 2019, JUL 22; 50(2): 229-+.
  1. 4.   Progress in targeting RAS with small molecule drugs
  2. McCormick, Frank
  3. The Biochemical journal. 2019, MAR 31; 476(2): 365-374.
  1. 5.   De Novo Assembly and Phasing of Dikaryotic Genomes from Two Isolates ofPuccinia coronataf. sp.avenae, the Causal Agent of Oat Crown Rust
  2. Miller, Marisa E; Zhang, Ying; Omidvar, Vahid; Sperschneider, Jana; Schwessinger, Benjamin; Raley, Castle; Palmer, Jonathan M; Garnica, Diana; Upadhyaya, Narayana; Rathjen, John; Taylor, Jennifer M; Park, Robert F; Dodds, Peter N; Hirsch, Cory D; Kianian, Shahryar F; Figueroa, Melania
  3. mBio. 2018, JAN-FEB; 9(1): pii: e01650-17.
  1. 6.   Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
  2. Li, Wei; Zhu, Zhongyu; Chen, Weizao; Feng, Yang; Dimitrov, Dimiter S.
  3. Frontiers in Immunology. 2017, Nov 13; 8: 1554.
  1. 7.   Th1 Differentiation Drives the Accumulation of Intravascular, Non-protective CD4 T Cells during Tuberculosis.
  2. Sallin, Michelle A; Sakai, Shunsuke; Kauffman, Keith D; Young, Howard; Zhu, Jinfang; Barber, Daniel L
  3. Cell reports. 2017, Mar 28; 18(13): 3091-3104.
  1. 8.   Analytical characterization of ch14.18 A mouse-human chimeric disialoganglioside-specific therapeutic antibody
  2. Soman, G.; Kallarakal, A. T.; Michiel, D.; Yang, X. Y.; Saptharishi, N.; Jiang, H. G.; Giardina, S.; Gilly, J.; Mitra, G.
  3. Mabs. 2012, Jan-Feb; 4(1): 84-100.
  1. 9.   Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity
  2. Chen, X.; Oppenheim, J. J.
  3. Febs Letters. 2011, Dec; 585(23): 3611-3618.
  1. 10.   Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature
  2. Muranski, P.; Borman, Z. A.; Kerkar, S. P.; Klebanoff, C. A.; Ji, Y.; Sanchez-Perez, L.; Sukumar, M.; Reger, R. N.; Yu, Z. Y.; Kern, S. J.; Roychoudhuri, R.; Ferreyra, G. A.; Shen, W.; Durum, S. K.; Feigenbaum, L.; Palmer, D. C.; Antony, P. A.; Chan, C. C.; Laurence, A.; Danner, R. L.; Gattinoni, L.; Restifol, N. P.
  3. Immunity. 2011, Dec; 35(6): 972-985.
  1. 11.   Depletion of CD4(+) T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques
  2. Ortiz, A. M.; Klatt, N. R.; Li, B.; Yi, Y.; Tabb, B.; Hao, X. P.; Sternberg, L.; Lawson, B.; Carnathan, P. M.; Cramer, E. M.; Engram, J. C.; Little, D. M.; Ryzhova, E.; Gonzalez-Scarano, F.; Paiardini, M.; Ansari, A. A.; Ratcliffe, S.; Else, J. G.; Brenchley, J. M.; Collman, R. G.; Estes, J. D.; Derdeyn, C. A.; Silvestri, G.
  3. Journal of Clinical Investigation. 2011, Nov; 121(11): 4433-4445.
  1. 12.   Enhanced Control of Pathogenic Simian Immunodeficiency Virus SIVmac239 Replication in Macaques Immunized with an Interleukin-12 Plasmid and a DNA Prime-Viral Vector Boost Vaccine Regimen
  2. Winstone, N.; Wilson, A. J.; Morrow, G.; Boggiano, C.; Chiuchiolo, M. J.; Lopez, M.; Kemelman, M.; Ginsberg, A. A.; Mullen, K.; Coleman, J. W.; Wu, C. D.; Narpala, S.; Ouellette, I.; Dean, H. J.; Lin, F.; Sardesai, N. Y.; Cassamasa, H.; McBride, D.; Felber, B. K.; Pavlakis, G. N.; Schultz, A.; Hudgens, M. G.; King, C. R.; Zamb, T. J.; Parks, C. L.; McDermott, A. B.
  3. Journal of Virology. 2011, Sep; 85(18): 9578-9587.
  1. 13.   Transduction of SIV-Specific TCR Genes into Rhesus Macaque CD8(+) T Cells Conveys the Ability to Suppress SIV Replication
  2. Barsov, E. V.; Trivett, M. T.; Minang, J. T.; Sun, H. S.; Ohlen, C.; Ott, D. E.
  3. Plos One. 2011, Aug; 6(8): 9.
  1. 14.   The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on CD4(+) FoxP3(+) regulatory T cells
  2. Chen, X.; Oppenheim, J. J.
  3. Immunology. 2011, Aug; 133(4): 426-433.
  1. 15.   Bifunctional fusion proteins of the human engineered antibody domain m36 with human soluble CD4 are potent inhibitors of diverse HIV-1 isolates
  2. Chen, W. Z.; Xiao, X. D.; Wang, Y. P.; Zhu, Z. Y.; Dimitrov, D. S.
  3. Antiviral Research. 2010, Oct; 88(1): 107-115.
  1. 16.   Increased CD4(+) T Cell Levels during IL-7 Administration of Antiretroviral Therapy-Treated Simian Immunodeficiency Virus-Positive Macaques Are Not Dependent on Strong Proliferative Responses
  2. Leone, A.; Rohankhedkar, M.; Okoye, A.; Legasse, A.; Axthelm, M. K.; Villinger, F.; Piatak, M.; Lifson, J. D.; Assouline, B.; Morre, M.; Picker, L. J.; Sodora, D. L.
  3. Journal of Immunology. 2010, Aug; 185(3): 1650-1659.
  1. 17.   Adaptive control of innate immunity
  2. Shanker, A.
  3. Immunology Letters. 2010, Jul; 131(2): 107-112.
  1. 18.   NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway
  2. Watanabe, T.; Asano, N.; Fichtner-Feigl, S.; Gorelick, P. L.; Tsuji, Y.; Matsumoto, Y.; Chiba, T.; Fuss, I. J.; Kitani, A.; Strober, W.
  3. Journal of Clinical Investigation. 2010, May; 120(5): 1645-1662.
  1. 19.   Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit
  2. Valentin, A.; von Gegerfelt, A.; Rosati, M.; Miteloudis, G.; Alicea, C.; Bergamaschi, C.; Jalah, R.; Patel, V.; Khan, A. S.; Draghia-Akli, R.; Pavlakis, G. N.; Felber, B. K.
  3. Vaccine. 2010, Feb; 28(8): 1962-1974.
  1. 20.   Application of a Flow Cytometric Cytotoxicity Assay for Monitoring Cancer Vaccine Trials
  2. Zaritskaya, L.; Shafer-Weaver, K. A.; Gregory, M. K.; Strobl, S. L.; Baseler, M.; Malyguine, A.
  3. Journal of Immunotherapy. 2009 32(2): 186-194.
  1. 21.   Characterization of the interaction of phorbol esters with the C1 domain of MRCK (myotonic dystrophy kinase-related Cdc42 binding kinase) alpha/beta
  2. Choi, S. H.; Czifra, G.; Kedei, N.; Lewin, N. E.; Lazar, J.; Pu, Y. M.; Marquez, V. E.; Blumberg, P. M.
  3. Journal of Biological Chemistry. 2008 283(16): 10543-10549.
  1. 22.   Multiple autophosphorylation sites are dispensable for murine ATM activation in vivo
  2. Daniel, J. A.; Pellegrini, M.; Lee, J. H.; Paull, T. T.; Feigenbaum, L.; Nussenzweig, A.
  3. Journal of Cell Biology. 2008 183(5): 777-783.
  1. 23.   Lytic Granule Loading of CD8(+) T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control
  2. Migueles, S. A.; Osborne, C. M.; Royce, C.; Compton, A. A.; Joshi, R. P.; Weeks, K. A.; Rood, J. E.; Berkley, A. M.; Sacha, J. B.; Cogliano-Shutta, N. A.; Lloyd, M.; Roby, G.; Kwan, R.; McLaughlin, M.; Stallings, S.; Rehm, C.; O'Shea, M. A.; Mican, J.
  3. Immunity. 2008 29(6): 1009-1021.
  1. 24.   Expression of the transcription factor cKrox in peripheral CD8 T cells reveals substantial postthymic plasticity in CD4-CD8 lineage differentiation
  2. Jenkinson, S. R.; Intlekofer, A. M.; Sun, G.; Feigenbaum, L.; Reiner, S. L.; Bosselut, R.
  3. Journal of Experimental Medicine. 2007, Feb; 204(2): 267-272.
  1. 25.   Sensitizing tumor cells to immune-mediated cytotoxicity
  2. Shanker, A.; Sayers, T.
  3. Immune-Mediated Diseases: From Theory to Therapy. 2007; 601 : 163-171.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel